Digestive & Intestinal Remedies (Pharmacies) - Uganda

  • Uganda
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$15.18m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.82%, resulting in a market volume of US$20.14m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.30 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Uganda has been experiencing significant growth in recent years. This can be attributed to several factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Uganda have been shifting towards natural and herbal remedies. Customers are becoming more conscious of the ingredients and potential side effects of pharmaceutical products, leading them to seek out alternative options. This preference for natural remedies has created opportunities for local manufacturers and suppliers of herbal products to expand their market share. Trends in the market also play a crucial role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Uganda. One notable trend is the increasing prevalence of digestive and intestinal disorders among the population. This can be attributed to changes in diet, lifestyle, and the overall increase in stress levels. As a result, there is a growing demand for remedies that can alleviate symptoms and provide relief from these conditions. Another trend in the market is the growing popularity of online pharmacies and e-commerce platforms. With the increasing penetration of the internet and smartphones in Uganda, more customers are turning to online platforms to purchase their healthcare products. This trend has allowed for greater accessibility and convenience, especially for customers in remote areas who may not have easy access to physical pharmacies. Local special circumstances also contribute to the development of the Digestive & Intestinal Remedies (Pharmacies) market in Uganda. The country has a high prevalence of gastrointestinal diseases, including diarrhea, dysentery, and stomach ulcers. This has created a significant demand for remedies that can effectively treat these conditions. Additionally, the government has been taking steps to improve healthcare infrastructure and increase access to essential medicines, further driving the growth of the market. Underlying macroeconomic factors also play a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Uganda. The country has been experiencing steady economic growth, resulting in an increase in disposable income levels. This has allowed more people to afford healthcare products and services, including digestive and intestinal remedies. Furthermore, the government has been implementing policies to promote the pharmaceutical industry and attract foreign investment, which has further stimulated the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Uganda is developing due to changing customer preferences towards natural remedies, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. As the market continues to grow, it presents opportunities for both local and international players to expand their presence and cater to the increasing demand for digestive and intestinal remedies in the country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)